Indoco Remedies to exit ophthalmic business in strategic sale to Sunways India

The transaction marks a clear portfolio reshuffle for Indoco

Parexel acquires Vitrana to strengthen AI-driven patient safety capabilities

Acquisition enhances integrated pharmacovigilance platform, combining AI, automation, and services to improve compliance, efficiency, and end-to-end clinical safety operations

Cardioline acquires Cardios to expand global telecardiology footprint

Backed by ARCHIMED, the deal strengthens connected cardiac diagnostics with integrated Holter, ABPM, and telemedicine solutions

Biosimilars gain momentum as US market sees 92 approvals: Samsung Bioepis report

Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation

Sun Pharma to acquire Organon in $11.75 billion all-cash deal

Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally

Siegfried locks in major CDMO expansion deal as US & Australia sites join global network from May 1

The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network

Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million

Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence

Boston Scientific surges into 2026 with double-digit sales growth & record quarterly profit jump

Growth was broad-based across segments

Pharma stocks face Q4 reality check amid global headwinds

Analysts expect modest revenue growth but pressure on profitability in the March quarter

Stereotaxis to acquire Robocath in deal aimed at expanding surgical robotics platform